MARKET WIRE NEWS

Longleaf Partners Global Fund Q2 2025 Commentary

Source: SeekingAlpha

2025-07-23 07:00:00 ET

Fund Characteristics

P/V Ratio

High-50s%

Cash

8.8%

# of Holdings

22

All data as of June 30, 2025

Annualized Total Return

2Q (%)

YTD (%)

1 Year (%)

3 Year (%)

5 Year (%)

10 Year (%)

Since Inception (%)

Global Fund

10.50

8.06

15.73

11.34

8.04

5.56

5.65

FTSE Developed

11.72

10.07

16.41

18.15

14.35

10.54

11.01

FTSE Developed Value

7.55

13.44

17.64

13.86

12.87

7.74

8.44

Inception date 12/27/2012. FTSE Developed Value Since Inception return is gross, as net return for that period is not available. All other performance figures above are net returns.

Read the full article on Seeking Alpha

For further details see:

Longleaf Partners Global Fund Q2 2025 Commentary
Regeneron Pharmaceuticals Inc.

NASDAQ: REGN

REGN Trading

0.51% G/L:

$781.46 Last:

155,403 Volume:

$769.17 Open:

mwn-ir Ad 300

REGN Latest News

March 08, 2026 08:20:00 am
2 Underrated Weight Loss Stocks to Buy Now

REGN Stock Data

$80,621,924,056
100,116,656
N/A
714
N/A
Biotechnology & Life Sciences
Healthcare
US
Tarrytown

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App